
Bausch Health Companies Inc.: shareholders and insiders
Price
$8.56
November 19, 2026Market cap $3.2B
What Ploutos Investor adds for Bausch Health Companies
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has risen 26% since Oct 28, 2026, when the 10-Q these figures come from was filed ($6.92 then, $8.73 on Nov 18, 2026). The figures date from before that move.10-Q
Insiders and their shares
Purchases and sales by officers and directors from Nov 19, 2025 to Oct 2, 2026, from their own Form 4 filings.
Bought on the market
$16M
1 person
Sold on the market
$506.7K
3 people
From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan100%
- The rest0%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $506.7K by 3 people
- 2025: bought $16M by 1 person, no sales
- 2026: no buys, sold $506.7K by 3 people
- Sep 30, 2026John PaulsonDirectorKind
- Sep 30, 2026Sandra LeungDirectorKind
- Sep 30, 2026Amy B WechslerDirectorKind
- Aug 19, 2026Aimee J. LenarPresident, US PharmaKind10b5-1
- Jul 17, 2026Aimee J. LenarPresident, US PharmaKind
- Jul 15, 2026Aimee J. LenarPresident, US PharmaKind
- Jul 14, 2026Steven Hyosig LeeSVP, Controller & CAOKind
- Jun 30, 2026Amy B WechslerDirectorKind
- Jun 30, 2026John PaulsonDirectorKind
- Jun 30, 2026Sandra LeungDirectorKind
- May 22, 2026Amy B WechslerDirectorKind
- May 22, 2026Eiry RobertsDirectorKind
- May 22, 2026Robert N PowerDirectorKind
- May 22, 2026John PaulsonDirectorKind
- May 22, 2026Sandra LeungDirectorKind
- May 22, 2026Frank D. LeeDirectorKind
- May 22, 2026Sarah B KavanaghDirectorKind
- May 22, 2026Michael GoettlerDirectorKind
- May 22, 2026Christian A GarciaDirectorKind
- May 19, 2026Frank D. LeeKind10b5-1
- Mar 3, 2026Seana CarsonEVP, General CounselKind10b5-1
- Mar 2, 2026Seana CarsonEVP, General CounselKind10b5-1
- Feb 27, 2026Seana CarsonEVP, General CounselKind10b5-1
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | John PaulsonDirector | 10.7K | $5.83 | $62.5K | Form 4 | |
| Sep 30, 2026 | Sandra LeungDirector | 5,789 | $5.83 | $33.7K | Form 4 | |
| Sep 30, 2026 | Amy B WechslerDirector | 1,179 | $5.83 | $6.9K | Form 4 | |
| Aug 19, 2026 | Aimee J. LenarPresident, US Pharma | 10b5-1 | 36.8K | $7.03 | $258.9K | Form 4 |
| Jul 17, 2026 | Aimee J. LenarPresident, US Pharma | 5,260 | $4.83 | $25.4K | Form 4 | |
| Jul 15, 2026 | Aimee J. LenarPresident, US Pharma | 23.4K | $4.89 | $114.4K | Form 4 | |
| Jul 14, 2026 | Steven Hyosig LeeSVP, Controller & CAO | 3,125 | $4.75 | $14.8K | Form 4 | |
| Jun 30, 2026 | Amy B WechslerDirector | 1,394 | $4.93 | $6.9K | Form 4 | |
| Jun 30, 2026 | John PaulsonDirector | 12.7K | $4.93 | $62.5K | Form 4 | |
| Jun 30, 2026 | Sandra LeungDirector | 6,845 | $4.93 | $33.7K | Form 4 | |
| May 22, 2026 | Amy B WechslerDirector | 45.9K | – | – | Form 4 | |
| May 22, 2026 | Eiry RobertsDirector | 45.9K | – | – | Form 4 | |
| May 22, 2026 | Robert N PowerDirector | 45.9K | – | – | Form 4 | |
| May 22, 2026 | John PaulsonDirector | 45.9K | – | – | Form 4 | |
| May 22, 2026 | Sandra LeungDirector | 45.9K | – | – | Form 4 | |
| May 22, 2026 | Frank D. LeeDirector | 45.9K | – | – | Form 4 | |
| May 22, 2026 | Sarah B KavanaghDirector | 45.9K | – | – | Form 4 | |
| May 22, 2026 | Michael GoettlerDirector | 45.9K | – | – | Form 4 | |
| May 22, 2026 | Christian A GarciaDirector | 45.9K | – | – | Form 4 | |
| May 19, 2026 | Frank D. Lee | 10b5-1 | 24.5K | $5.43 | $132.8K | Form 4 |
| Mar 3, 2026 | Seana CarsonEVP, General Counsel | 10b5-1 | 4,420 | $5.77 | $25.5K | Form 4 |
| Mar 2, 2026 | Seana CarsonEVP, General Counsel | 10b5-1 | 6,856 | $5.78 | $39.6K | Form 4 |
| Feb 27, 2026 | Seana CarsonEVP, General Counsel | 10b5-1 | 8,388 | $5.95 | $49.9K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before May 26, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by BHC's officers and directors from 2010 up to November 18, 2025, 16 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 11 more, back to 2010
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- PaulsonCommon Shares, no par valueShare of class19.1%
- Alex MerueloCommon shares, no par valueShare of class9.99%
- GoldenTree Asset Management LPwith 2 more personsCommon Shares, no par valueShare of class9.50%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| PaulsonCommon Shares, no par value | 19.1% | 70.76M | Aug 14, 20253 filings since May 21, 2025 | 13D/A | |
| Alex MerueloCommon shares, no par value | 9.99% | 36.76M | Apr 7, 2025 | 13D | |
| GoldenTree Asset Management LPwith 2 more personsCommon Shares, no par value | 9.50% | 35.24M | Aug 14, 2025 | 13G/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Alex Meruelo10.0%From the filing of Apr 7, 2025
On March 31, 2025, Mr. Meruelo spoke with Thomas Appio, the Chief Executive Officer of the Issuer, regarding the market reaction to the Issuer's recently announced debt refinancing as well as the Issuer's future debt maturities and plans to maximize shareholder value. During the course of the conversation, it became clear to the Reporting Person that the Issuer could benefit from the Reporting Person's financial and business experience and, therefore, the Reporting Person expressed his willingness to join the board of directors of the Issuer (the "Board") and to help the Issuer identify other strategic individuals to join the Board. The Reporting Person has since determined to continue to…
From the filing of Apr 7, 2025
Fell to 5% or less (2)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter+48%
- Bridgewater (Dalio)In the quarter+8.8%
- Renaissance TechnologiesIn the quarter+55%
- Citadel Advisors (Griffin)In the quarter+96%
- Millennium Mgmt (Englander)In the quarter+19%
- D.E. ShawIn the quarter+30%
- AQR CapitalIn the quarter+220%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | 3.31M | +48% | $19M | 0.03% |
| Bridgewater (Dalio) | 942.6K | +8.8% | $5.5M | 0.02% |
| Renaissance Technologies | 2.06M | +55% | $12M | 0.02% |
| Citadel Advisors (Griffin) | 2.17M | +96% | $13M | 0.01% |
| Millennium Mgmt (Englander) | 1.31M | +19% | $7.6M | 0.01% |
| D.E. Shaw | 3.51M | +30% | $21M | 0.01% |
| AQR Capital | 263.6K | +220% | $1.5M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 2.22% of its shares outstanding were held short, -1.9% since the report before.
- Shares held short
- 8.24M
- 2.22%
- Since the report before8.40M on Sep 30, 2026
- -1.9%
- 4.2
- 1.98M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 51%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 21.42M
- Nov 15, 2023: Shares held short 21.92M
- Nov 30, 2023: Shares held short 22.12M
- Dec 15, 2023: Shares held short 21.43M
- Dec 29, 2023: Shares held short 21.10M
- Jan 12, 2024: Shares held short 21.54M
- Jan 31, 2024: Shares held short 21.31M
- Feb 15, 2024: Shares held short 21.53M
- Feb 29, 2024: Shares held short 24.64M
- Mar 15, 2024: Shares held short 23.78M
- Mar 28, 2024: Shares held short 22.50M
- Apr 15, 2024: Shares held short 20.71M
- Apr 30, 2024: Shares held short 20.51M
- May 15, 2024: Shares held short 18.50M
- May 31, 2024: Shares held short 17.57M
- Jun 14, 2024: Shares held short 18.02M
- Jun 28, 2024: Shares held short 18.44M
- Jul 15, 2024: Shares held short 18.27M
- Jul 31, 2024: Shares held short 19.72M
- Aug 15, 2024: Shares held short 19.98M
- Aug 30, 2024: Shares held short 19.83M
- Sep 13, 2024: Shares held short 18.60M
- Sep 30, 2024: Shares held short 14.78M
- Oct 15, 2024: Shares held short 12.03M
- Oct 31, 2024: Shares held short 11.65M
- Nov 15, 2024: Shares held short 9.34M
- Nov 29, 2024: Shares held short 10.26M
- Dec 13, 2024: Shares held short 8.00M
- Dec 31, 2024: Shares held short 7.03M
- Jan 15, 2025: Shares held short 8.25M
- Jan 31, 2025: Shares held short 6.91M
- Feb 14, 2025: Shares held short 7.77M
- Feb 28, 2025: Shares held short 6.45M
- Mar 14, 2025: Shares held short 6.06M
- Mar 31, 2025: Shares held short 7.85M
- Apr 15, 2025: Shares held short 9.02M
- Apr 30, 2025: Shares held short 9.86M
- May 15, 2025: Shares held short 8.17M
- May 30, 2025: Shares held short 8.61M
- Jun 13, 2025: Shares held short 8.68M
- Jun 30, 2025: Shares held short 8.32M
- Jul 15, 2025: Shares held short 7.44M
- Jul 31, 2025: Shares held short 7.29M
- Aug 15, 2025: Shares held short 8.30M
- Aug 29, 2025: Shares held short 8.26M
- Sep 15, 2025: Shares held short 7.93M
- Sep 30, 2025: Shares held short 7.71M
- Oct 15, 2025: Shares held short 7.46M
- Oct 31, 2025: Shares held short 6.48M
- Nov 14, 2025: Shares held short 6.66M
- Nov 28, 2025: Shares held short 5.65M
- Dec 15, 2025: Shares held short 6.41M
- Dec 31, 2025: Shares held short 4.84M
- Jan 15, 2026: Shares held short 5.03M
- Jan 30, 2026: Shares held short 5.41M
- Feb 13, 2026: Shares held short 5.60M
- Feb 27, 2026: Shares held short 5.54M
- Mar 13, 2026: Shares held short 6.30M
- Mar 31, 2026: Shares held short 5.99M
- Apr 15, 2026: Shares held short 6.28M
- Apr 30, 2026: Shares held short 6.37M
- May 15, 2026: Shares held short 5.97M
- May 29, 2026: Shares held short 6.12M
- Jun 15, 2026: Shares held short 7.44M
- Jun 30, 2026: Shares held short 7.33M
- Jul 15, 2026: Shares held short 7.37M
- Jul 31, 2026: Shares held short 7.56M
- Aug 14, 2026: Shares held short 8.42M
- Aug 31, 2026: Shares held short 8.22M
- Sep 15, 2026: Shares held short 8.63M
- Sep 30, 2026: Shares held short 8.40M
- Oct 15, 2026: Shares held short 8.24M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading28.5% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 28.5% of the shares in the reported trades were short sales, against 46.5% in the 14 before.
- Last 14 sessionsOct 30, 2026 – Nov 18, 2026
- 28.5%
- The 14 beforeOct 12, 2026 – Oct 29, 2026
- 46.5%
- Change
- -18.0 pts
- Short sales a dayon average, of 1.30M shares
- 370.9K
- More than atof 3,656 US-listed companies, same days
- 4%
- Median of alleight in ten from 34.4% to 63.7%
- 50.3%
- Short sales
- Oct 12, 2026: Short sales 54.4%
- Oct 13, 2026: Short sales 46.1%
- Oct 14, 2026: Short sales 40.9%
- Oct 15, 2026: Short sales 43.7%
- Oct 16, 2026: Short sales 48%
- Oct 19, 2026: Short sales 32.7%
- Oct 20, 2026: Short sales 39%
- Oct 21, 2026: Short sales 63.1%
- Oct 22, 2026: Short sales 52.1%
- Oct 23, 2026: Short sales 45%
- Oct 26, 2026: Short sales 49.7%
- Oct 27, 2026: Short sales 60.2%
- Oct 28, 2026: Short sales 68.1%
- Oct 29, 2026: Short sales 38.8%
- Oct 30, 2026: Short sales 27.5%
- Nov 2, 2026: Short sales 30.5%
- Nov 3, 2026: Short sales 30.7%
- Nov 4, 2026: Short sales 22.5%
- Nov 5, 2026: Short sales 18.2%
- Nov 6, 2026: Short sales 23.1%
- Nov 9, 2026: Short sales 16.9%
- Nov 10, 2026: Short sales 33.3%
- Nov 11, 2026: Short sales 27.4%
- Nov 12, 2026: Short sales 37%
- Nov 13, 2026: Short sales 45.3%
- Nov 16, 2026: Short sales 34.4%
- Nov 17, 2026: Short sales 22.2%
- Nov 18, 2026: Short sales 36.5%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- John PaulsonDirectorDirectly2.94M
- Paulson & Co. Inc.TenPercentOwnerDirectly–
- Seana CarsonEVP, General CounselDirectly616.8K
- Aimee J. LenarPresident, US PharmaDirectly334.9K
- Amy B WechslerDirectorDirectly316.2K
- Robert N PowerDirectorDirectly300.6K
- Sarah B KavanaghDirectorDirectly282.2K
- Christian A GarciaDirectorDirectly135.6K
- Sandra LeungDirectorDirectly102.9K
- Frank D. LeeDirectorDirectly95.2K
- Michael GoettlerDirectorDirectly76.0K
- Steven Hyosig LeeSVP, Controller & CAODirectly70.1K
- Eiry RobertsDirectorDirectly45.9K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| John PaulsonDirector | 2.94M | 70.76M | Sep 30, 2026 | Form 4 |
| Paulson & Co. Inc.TenPercentOwner | – | 73.26M | Nov 25, 2025 | Form 4 |
| Seana CarsonEVP, General Counsel | 616.8K | – | Mar 3, 2026 | Form 4 |
| Aimee J. LenarPresident, US Pharma | 334.9K | – | Aug 19, 2026 | Form 4 |
| Amy B WechslerDirector | 316.2K | – | Sep 30, 2026 | Form 4 |
| Robert N PowerDirector | 300.6K | – | May 22, 2026 | Form 4 |
| Sarah B KavanaghDirector | 282.2K | – | May 22, 2026 | Form 4 |
| Christian A GarciaDirector | 135.6K | – | May 22, 2026 | Form 4 |
| Sandra LeungDirector | 102.9K | – | Sep 30, 2026 | Form 4 |
| Frank D. LeeDirector | 95.2K | – | May 22, 2026 | Form 4 |
| Michael GoettlerDirector | 76.0K | – | May 22, 2026 | Form 4 |
| Steven Hyosig LeeSVP, Controller & CAO | 70.1K | – | Jul 14, 2026 | Form 4 |
| Eiry RobertsDirector | 45.9K | – | May 22, 2026 | Form 4 |
A lower bound: it counts only the 13 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- PPHVanEck Pharmaceutical ETFWeight in the fund0.10%
- VSSVanguard Ftse All-World Ex-Us Small-Cap Index FundWeight in the fund0.05%
- FNDFSchwab Fundamental International Equity ETFWeight in the fund0.04%
- DFICDimensional International Core Equity 2 ETFWeight in the fund0.01%
- IDEViShares Core MSCI International Developed Markets ETFWeight in the fund0.01%
- DFAXDimensional World ex. U.S. Core Equity 2 ETFWeight in the fund0.01%
- SPDWState Street(R) SPDR(R) Portfolio Developed World ex-US ETFWeight in the fund0.00%
- IXUSiShares Core MSCI Total International Stock ETFWeight in the fund0.00%
- AVDEAvantis International Equity ETFWeight in the fund0.00%
- VXUSVanguard Total International Stock Index FundWeight in the fund0.00%
13 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 219
- Q4 2025: Managers 235
- Q1 2026: Managers 228
- Q2 2026: Managers 220
Institutional investors by quarter
The fund managers holding BHC, quarter by quarter, from Q2 2015 to Q2 2025, 34 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 220 managers held 237M shares, worth $1.2B. During the quarter 28 opened a position, 36 closed one, 64 added and 64 trimmed.
The largest holders, Q2 2026
- PaulsonIn the quarter
- Goldentree Asset ManagementIn the quarter
- Royal Bank of CanadaIn the quarter-4.7%
- Healthcare of Ontario Pension Plan Trust FundIn the quarter
- Vanguard Capital ManagementIn the quarter+0.8%
- Goldman Sachs GroupIn the quarter+20%
- MFN Partners ManagementIn the quarter
- SG Americas SecuritiesIn the quarter×374
- Acadian Asset ManagementIn the quarter+12%
- Kohlberg Kravis RobertsIn the quarter
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Paulson | 73.26M | $361M | |
| Goldentree Asset Management | 34.67M | $171M | |
| Royal Bank of Canada | 10.83M | -4.7% | $53M |
| Healthcare of Ontario Pension Plan Trust Fund | 8.00M | $39M | |
| Vanguard Capital Management | 7.47M | +0.8% | $37M |
| Goldman Sachs Group | 6.23M | +20% | $31M |
| MFN Partners Management | 6.00M | $30M | |
| SG Americas Securities | 5.54M | ×374 | $27M |
| Acadian Asset Management | 5.48M | +12% | $27M |
| Kohlberg Kravis Roberts | 5.24M | $26M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Bausch Health Companies's filings show?
Who buys and sells is one part of Bausch Health Companies's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have BHC's insiders bought or sold?
From May 26, 2026 to Oct 2, 2026 Bausch Health Companies's insiders bought 0 and sold $258.9K of shares on the market. 100% of the sales were under set 10b5-1 plans.
Which well-known managers hold BHC?
7 of the managers we track held the shares on Sep 30, 2026. The largest position was D.E. Shaw's, worth $21M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.